According to BioIntel360, the United States cell and gene therapy market size is expected to record a CAGR of 30.6% during 2023-2027 to reach US$21,027.6 million by 2027, increasing from US$7,226.1 mi...
According to BioIntel360, the United States cell and gene therapy market size is expected to record a CAGR of 30.6% during 2023-2027 to reach US$21,027.6 million by 2027, increasing from US$7,226.1 million in 2023. Over the last five years, the sector has recorded a CAGR of 30.5% to reach US$5,535.9 million in 2022. This report provides an in-depth data-centric analysis of the emerging opportunities in the cell and gene therapy industry. It covers a detailed view of market size and forecast across various segments such as by different therapy segment, type of therapy, the purpose of manufacturing, type of cell, route of administration, delivery mode, source of cell, source of manufacturing, therapeutic class, technology, end-user and by product. This databook is a part of the title “Global Cell & Gene Therapy Business and Investment Opportunities – Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, Competitive Landscape – Q1 2023 Update”.
This report provides an in-depth, data-centric analysis of the United States cell and gene therapy market 2018-2027. Below is a summary of key market segments: Cell & Gene Therapy Market Size by Different Therapy Segment, 2018-2027 • Cell and Gene Modified Cell Therapies • Gene Therapy and Genome Therapy • DNA & RNA Therapeutics Cell & Gene Therapy Market Size by Purpose of Manufacturing • Commercial • Clinical Cell & Gene Therapy Market Size by Product • Abecma • Amondys • Breyanzi • Carvykti • Givlaari • Kimmtrak • Kymriah • Leqvio • Luxturna • Onpattro • Oxlumo • Rethymic • Skysona • Stratagraft • Tecartus • Tegsedi • Viltepso • Vyondys • Yescarta • Zolgensma • Zynteglo Cell & Gene Therapy Market Size by Route of Administration • Injectables • Infusions • Bioscaffolds • Topicals Cell & Gene Therapy Market Size by Type of Cell • CAR-T Cell • TCR Cell Cell & Gene Therapy Market Size by Type of Therapy • T-Cell Therapies • NK Cell • Dendritic Cell Therapies • Stem Cell Therapies Cell & Gene Therapy Market Size by Source of Cell • Autologous • Allogenic Cell & Gene Therapy Market Size by Delivery Mode • In vivo • ex-vivo Cell & Gene Therapy Market Size by Source of Manufacturing • In-House • Contract Manufacturing Cell & Gene Therapy Market Size by Therapeutic Class • Oncology • Neurology • Ophthalmology • Musculoskeletal • Others Cell & Gene Therapy Market Size by Technology • Viral Vector Technology • Cell Immortalization Technology • Genome Editing Technology • Others Cell & Gene Therapy Market Size by End User • Pharmaceutical & Biotechnology Companies • Academic & Research Institutes • Hospital & Clinics
• In-depth understanding of cell and gene therapy market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in United States. • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry. • Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and by hospitals & clinics within the United States.
1 United States Cell and Gene Therapy Market Size and Forecast, 2018-2027 2 United States Cell and Gene Therapy Market Share by Different Therapy Segment, 2018-2027 2.1 United States Market Size by Cell and Gene Modified Cell Therapies, 2018-2027 2.2 United States Market Size by Gene Therapy and Genome Therapy, 2018-2027 2.3 United States Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, 2018-2027 3 United States Cell and Gene Therapy Market Share by Purpose of Manufacturing, 2018-2027 3.1 United States Cell and Gene Therapy Market Size by Commercial, 2018-2027 3.2 United States Cell and Gene Therapy Market Size by Clinical, 2018-2027 4 United States Cell and Gene Therapy Market Share by Product, 2018-2027 5 United StatesCell and Gene Therapy Market Share by Route of Administration, 2018-2027 5.1 United StatesCell and Gene Therapy Market Size by Injectables, 2018-2027 5.2 United StatesCell and Gene Therapy Market Size by Topicals, 2018-2027 5.3 United StatesCell and Gene Therapy Market Size by Infusions, 2018-2027 5.4 United StatesCell and Gene Therapy Market Size by Bioscaffolds, 2018-2027 6 United StatesCell and Gene Therapy Market Share by Type of Diseases, 2018-2027 6.1 United StatesCell and Gene Therapy Market Size by Rare Diseases, 2018-2027 6.2 United StatesCell and Gene Therapy Market Size by Non-Rare Diseases, 2018-2027 7 United StatesCell and Gene Therapy Market Share by Type of Cell, 2018-2027 7.1 United StatesCell and Gene Therapy Market Size by CAR-T Cell, 2018-2027 7.2 United StatesCell and Gene Therapy Market Size by TCR Cell, 2018-2027 8 United StatesCell and Gene Therapy Market Share by Therapy, 2018-2027 8.1 United StatesCell and Gene Therapy Market Size by T-Cell Therapies, 2018-2027 8.2 United StatesCell and Gene Therapy Market Size by NK Cell, 2018-2027 8.3 United StatesCell and Gene Therapy Market Size by Dendritic Cell Therapies, 2018-2027 8.4 United StatesCell and Gene Therapy Market Size by Stem Cell Therapies, 2018-2027 9 United StatesCell and Gene Therapy Market Share by Source of Cell, 2018-2027 9.1 United StatesCell and Gene Therapy Market Size by Autologous, 2018-2027 9.2 United StatesCell and Gene Therapy Market Size by Allogenic, 2018-2027 10 United StatesCell and Gene Therapy Market Share by Delivery Mode, 2018-2027 10.1 United StatesCell and Gene Therapy Market Size by In-vivo, 2018-2027 10.2 United StatesCell and Gene Therapy Market Size by Ex-vivo, 2018-2027 11 United StatesCell and Gene Therapy Market Share by Source of Manufacturing, 2018-2027 11.1 United StatesCell and Gene Therapy Market Size by In-House, 2018-2027 11.2 United StatesCell and Gene Therapy Market Size by Contract Manufacturing, 2018-2027 12 United StatesCell and Gene Therapy Market Share by Therapeutic Class, 2018-2027 12.1 United StatesCell and Gene Therapy Market Size by Oncology, 2018-2027 12.2 United StatesCell and Gene Therapy Market Size by Neurology, 2018-2027 12.3 United StatesCell and Gene Therapy Market Size by Ophthalmology, 2018-2027 12.4 United StatesCell and Gene Therapy Market Size by Musculoskeletal, 2018-2027 12.5 United StatesCell and Gene Therapy Market Size by Others, 2018-2027 13 United StatesCell and Gene Therapy Market Share by Technology, 2018-2027 13.1 United StatesCell and Gene Therapy Market Size by Viral Vector Technology, 2018-2027 13.2 United StatesCell and Gene Therapy Market Size by Cell Immortalization Technology, 2018-2027 13.3 United StatesCell and Gene Therapy Market Size by Genome Editing Technology, 2018-2027 13.4 United StatesCell and Gene Therapy Market Size by Others Technologies, 2018-2027 14 United StatesCell and Gene Therapy Market Share by End User, 2018-2027 14.1 United StatesCell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, 2018-2027 14.2 United StatesCell and Gene Therapy Market Size by Academic & Research Institutes, 2018-2027 14.3 United StatesCell and Gene Therapy Market Size by Hospital & Clinics, 2018-2027
Table 1: United States Cell and Gene Therapy Market Size by Value (USD MM) 2018-2027 Table 2: United States Cell and Gene Therapy Market Size by Cell and Gene Modified Cell Therapies, by Value (USD MM), 2018-2027 Table 3: United States Cell and Gene Therapy Market Size by Gene Therapy and Genome Therapy, by Value (USD MM) 2018-2027 Table 4: United States Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, by Value (USD MM) 2018-2027 Table 5: United States Cell and Gene Therapy Market Size by Commercial, by Value (USD MM) 2018-2027 Table 6: United States Cell and Gene Therapy Market Size by Clinical, by Value (USD MM) 2018-2027 Table 7: United States Cell and Gene Therapy Market Size by Injectables, by Value (USD MM) 2018-2027 Table 8: United States Cell and Gene Therapy Market Size by Topicals, by Value (USD MM) 2018-2027 Table 9: United States Cell and Gene Therapy Market Size by Infusions, by Value (USD MM) 2018-2027 Table 10: United States Cell and Gene Therapy Market Size by Bio scaffolds, by Value (USD MM) 2018-2027 Table 11: United States Cell and Gene Therapy Market Size by Rare Diseases, by Value (UDS MM) 2018-2027 Table 12: United States Cell and Gene Therapy Market Size by Non-Rare Diseases, by Value (UDS MM) 2018-2027 Table 13: United States Cell and Gene Therapy Market Size by CAR-T Cell, by Value (UDS MM) 2018-2027 Table 14: United States Cell and Gene Therapy Market Size by TCR Cell, by Value (UDS MM) 2018-2027 Table 15: United States Cell and Gene Therapy Market Size by T-Cell Therapies, by Value (USD MM), 2018-2027 Table 16: United States Cell and Gene Therapy Market Size by NK Cell, by Value (USD MM), 2018-2027 Table 17: United States Cell and Gene Therapy Market Size by Dendritic Cell Therapies, by Value (USD MM), 2018-2027 Table 18: United States Cell and Gene Therapy Market Size by Stem Cell Therapies, by Value (USD MM), 2018-2027 Table 19: United States Cell and Gene Therapy Market Size by Autologous (USD MM), 2018-2027 Table 20: United States Cell and Gene Therapy Market Size by Allogenic (USD MM), 2018-2027 Table 21: United States Cell and Gene Therapy Market Size by In-vivo, by Value (USD MM), 2018-2027 Table 22: United States Cell and Gene Therapy Market Size by Ex-vivo, by Value (USD MM), 2018-2027 Table 23: United States Cell and Gene Therapy Market Size by In-House, by Value (USD MM), 2018-2027 Table 24: United States Cell and Gene Therapy Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 Table 25: United States Cell and Gene Therapy Market Size by Oncology, by Value (USD MM), 2018-2027 Table 26: United States Cell and Gene Therapy Market Size by Neurology, by Value (USD MM), 2018-2027 Table 27: United States Cell and Gene Therapy Market Size by Ophthalmology, by Value (USD MM), 2018-2027 Table 28: United States Cell and Gene Therapy Market Size by Musculoskeletal, by Value (USD MM), 2018-2027 Table 29: United States Cell and Gene Therapy Market Size by Others, by Value (USD MM), 2018-2027 Table 30: United States Cell and Gene Therapy Market Size by Viral Vector Technology, by Value (USD MM), 2018-2027 Table 31: United States Cell and Gene Therapy Market Size by Cell Immortalization Technology, by Value (USD MM), 2018-2027 Table 32: United States Cell and Gene Therapy Market Size by Genome Editing Technology, by Value (USD MM), 2018-2027 Table 33: United States Cell and Gene Therapy Market Size by Others Technologies, by Value (USD MM), 2018-2027 Table 34: United States Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, by Value (USD MM), 2018-2027 Table 35: United States Cell and Gene Therapy Market Size by Academic & Research Institutes, by Value (USD MM), 2018-2027 Table 36: United States Cell and Gene Therapy Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027
Figure 1: United States Cell and Gene Therapy Market Size by Value (USD MM) 2018-2027 Figure 2: United States Cell and Gene Therapy Market Share by Different Therapy Segment (%), 2018-2027 Figure 3: United States Cell and Gene Therapy Market Size by Cell and Gene Modified Cell Therapies, by Value (USD MM), 2018-2027 Figure 4: United States Cell and Gene Therapy Market Size by Gene Therapy and Genome Therapy, by Value (USD MM) 2018-2027 Figure 5: United States Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, by Value (USD MM) 2018-2027 Figure 6: United States Cell and Gene Therapy Market Share Purpose of Manufacturing (%), 2018-2027 Figure 7: United States Cell and Gene Therapy Market Size by Commercial, by Value (USD MM) 2018-2027 Figure 8: United States Cell and Gene Therapy Market Size, By Clinical, by Value (USD MM) 2018-2027 Figure 9: United States Cell and Gene Therapy Market Share by Product (%), 2018-2027 Figure 10: United States Cell and Gene Therapy Market Share by Route of Administration (%), 2018-2027 Figure 11: United States Cell and Gene Therapy Market Size by Injectables, by Value (USD MM) 2018-2027 Figure 12: United States Cell and Gene Therapy Market Size by Topicals, by Value (USD MM) 2018-2027 Figure 13: United States Cell and Gene Therapy Market Size by Infusions, by Value (USD MM) 2018-2027 Figure 14: United States Cell and Gene Therapy Market Size by Bio scaffolds, by Value (USD MM) 2018-2027 Figure 15: United States Cell and Gene Therapy Market Share by Type of Diseases (%), 2018-2027 Figure 16: United States Cell and Gene Therapy Market Share by Rare Diseases, by Value (UDS MM) 2018-2027 Figure 17: United States Cell and Gene Therapy Market Share by Non-Rare Diseases, by Value (UDS MM) 2018-2027 Figure 18: United States Cell and Gene Therapy Market Share by Type of Cell (%), 2018-2027 Figure 19: United States Cell and Gene Therapy Market Share by CAR-T Cell, by Value (UDS MM) 2018-2027 Figure 20: United States Cell and Gene Therapy Market Share by TCR Cell, by Value (UDS MM) 2018-2027 Figure 21: United States Cell and Gene Therapy Market Share by Therapy (%), 2018-2027 Figure 22: United States Cell and Gene Therapy Market Size by T-Cell Therapies, by Value (USD MM), 2018-2027 Figure 23: United States Cell and Gene Therapy Market Size by NK Cell, by Value (USD MM), 2018-2027 Figure 24: United States Cell and Gene Therapy Market Size by Dendritic Cell Therapies, by Value (USD MM), 2018-2027 Figure 25: United States Cell and Gene Therapy Market Size by Stem Cell Therapies, by Value (USD MM), 2018-2027 Figure 26: United States Cell and Gene Therapy Market Share by Source of Cell (%), 2018-2027 Figure 27: United States Cell and Gene Therapy Market Size by Autologous (USD MM), 2018-2027 Figure 28: United States Cell and Gene Therapy Market Size by Allogenic (USD MM), 2018-2027 Figure 29: United States Cell and Gene Therapy Market Share by Delivery Mode (%), 2018-2027 Figure 30: United States Cell and Gene Therapy Market Size by In-vivo, by Value (USD MM), 2018-2027 Figure 31: United States Cell and Gene Therapy Market Size by Ex-vivo, by Value (USD MM), 2018-2027 Figure 32: United States Cell and Gene Therapy Market Share by Source of Manufacturing (%), 2018-2027 Figure 33: United States Cell and Gene Therapy Market Size by In-House, by Value (USD MM), 2018-2027 Figure 34: United States Cell and Gene Therapy Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 Figure 35: United States Cell and Gene Therapy Market Share by Therapeutic Class (%), 2018-2027 Figure 36: United States Cell and Gene Therapy Market Size by Oncology, by Value (USD MM), 2018-2027 Figure 37: United States Cell and Gene Therapy Market Size by Neurology, by Value (USD MM), 2018-2027 Figure 38: United States Cell and Gene Therapy Market Size by Ophthalmology, by Value (USD MM), 2018-2027 Figure 39: United States Cell and Gene Therapy Market Size by Musculoskeletal, by Value (USD MM), 2018-2027 Figure 40: United States Cell and Gene Therapy Market Size by Others, by Value (USD MM), 2018-2027 Figure 41: United States Cell and Gene Therapy Market Share by Technology (%), 2018-2027 Figure 42: United States Cell and Gene Therapy Market Size by Viral Vector Technology, by Value (USD MM), 2018-2027 Figure 43: United States Cell and Gene Therapy Market Size by Cell Immortalization Technology, by Value (USD MM), 2018-2027 Figure 44: United States Cell and Gene Therapy Market Size by Genome Editing Technology, by Value (USD MM), 2018-2027 Figure 45: United States Cell and Gene Therapy Market Size by Others Technologies, by Value (USD MM), 2018-2027 Figure 46: United States Cell and Gene Therapy Market Share by End User (%), 2018-2027 Figure 47: United States Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, by Value (USD MM), 2018-2027 Figure 48: United States Cell and Gene Therapy Market Size by Academic & Research Institutes, by Value (USD MM), 2018-2027 Figure 49: United States Cell and Gene Therapy Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027
